Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Randomized Phase 3 Study of S-1 Monotherapy vs S-1 + Cisplatin vs 5-FU + Cisplatin in Advanced Gastric Cancer
jRCT1080220049Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gastric adenocarcinoma and gastric cancer (GC) comparing S-1 monotherapy, S-1 + cisplatin and 5-FU + cisplatin (3 arms).
02
Drugs
tegafurcisplatinfluorouracil
03
Conditions
gastric adenocarcinomagastric cancer (GC)
Beyond the preview
Go deeper on jRCT1080220049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220049.